BioCentury | Oct 26, 2009
Company News

Paladin, Pfizer sales and marketing update

...Paladin and Pfizer's Pfizer Canada Inc. amended a 2002 agreement for Pfizer's Estring estradiol. The intravaginal...
...Paladin Labs will take over all commercial responsibilities for the sales, marketing and distribution of Estring...
BioCentury | Sep 4, 2006

Back to School 2006: Value for money

Thirteen years ago BioCentury sketched a picture called "The Clear Route to ROI" to depict the gap between the perceptions of value creation held by biotechnology companies and those of investors. Today a more mature...
BioCentury | Jan 22, 2002
Company News

Paladin, Pharmacia sales and marketing update PHA. The companies will share revenues equally. Products include PHA's Dostinex to treat hyperprolactinemia, Estring...
Items per page:
1 - 3 of 3